Close Menu

microbiome analysis

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Microbiome technology firm Second Genome today announced the closing of a Series A financing round that raised $5 million.

Bringing together new and published metagenome data on gut microbes for dozens of individuals from six countries, researchers have identified three types of stable gut microbe communities, dubbed enterotypes.

Three research projects that will use genomics research into preterm birth were among the recipients of the grants, each for $600,000 over four years.

The company is collaborating with Argonne National Laboratory, Lawrence Berkeley National Laboratory, and the University of Colorado at Boulder to develop automated protocols for DNA extraction and library preparation workflows.

The Institute for Genome Sciences expects to start using the new Pacific Biosciences platform by the spring, as well as carry out projects related to the Human Microbiome Project, explore how to build up its computational capabilities through existing clouds, and hire two new faculty members.

Faculty from the University of Maryland Institute for Genome Sciences will work closely with the new enterprise in its study of the interaction between the human body and the microbes that inhabit it.

Michigan State University scientists will use the funding to study gut microbes and the effect they have on diseases.

Researchers from Washington University and elsewhere used Roche 454 sequencing to begin characterizing the viruses found in the feces of dozens of individuals over time.

Pages

Mainichi reports that 43 percent of Japanese individuals said they did not want to eat agricultural products that had been modified using gene-editing tools.

Two US Department of Agriculture research departments are moving to the Kansas City area, according to the Washington Post.

Slate's Jane Hu compares some at-home genetic tests to astrology.

In PLOS this week: analysis of polygenic risk scores for skin cancer, chronic pain GWAS, and more.